ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Results available

Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer

ClinicalTrials.gov ID: NCT05169567

Public ClinicalTrials.gov record NCT05169567. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

postMONARCH: A Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Compare the Efficacy of Abemaciclib Plus Fulvestrant to Placebo Plus Fulvestrant in Participants With HR+, HER2-, Advanced or Metastatic Breast Cancer Following Progression on a CDK4 & 6 Inhibitor and Endocrine Therapy

Study identification

NCT ID
NCT05169567
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
368 participants

Conditions and interventions

Interventions

  • Abemaciclib Drug
  • Fulvestrant Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 10, 2022
Primary completion
Feb 7, 2024
Completion
Nov 30, 2027
Last update posted
Jan 15, 2026

2022 – 2027

United States locations

U.S. sites
60
U.S. states
21
U.S. cities
55
Facility City State ZIP Site status
St. Joseph's Hospital and Medical Center Phoenix Arizona 85004
Highlands Oncology Group Springdale Arkansas 72762
Providence Medical Foundation Fullerton California 92835
Cancer and Blood Specialty Clinic Los Alamitos California 90720
TRIO-US (Translational Research in Oncology-US) Los Angeles California 90024
Keck School of Medicine of USC Los Angeles California 90033
UCLA Hematology/Oncology - Parkside Santa Monica California 90404
Olive View-UCLA Medical Center Sylmar California 91342
Torrance Memorial Physician Network / Cancer Care Torrance California 90505
PIH Health Hematology Medical Oncology Whittier California 90602
Rocky Mountain Cancer Center - Hale Parkway Denver Colorado 80220
Florida Cancer Specialists SOUTH/Sarah Cannon Research Institute/SCRI Fort Myers Florida 33901-8101
Millennium Oncology Research Clinic Hollywood Florida 33024
University of Miami Hospital and Clinics, Sylvester Cancer Center Miami Florida 33136
Woodlands Medical Specialists, PA Pensacola Florida 32503
Florida Cancer Specialists SOUTH/Sarah Cannon Research Institute/SCRI Sarasota Florida 34232
Florida Cancer Specialists EAST/Sarah Cannon Research Institute/SCRI West Palm Beach Florida 33401
Winship Cancer Institute, Emory University Atlanta Georgia 30322
Northeast Georgia Medical Center Gainesville Georgia 30501
Central Georgia Cancer Care Macon Georgia 31201
Kapiolani Medical Center for Women and Children Honolulu Hawaii 96826
Ingalls Memorial Hospital Harvey Illinois 60426
Hematology Oncology Clinic- Baton Rouge/Sarah Cannon Research Institute/SCRI Baton Rouge Louisiana 70809
Clinical Trials of SWLA Lake Charles Louisiana 70601
Central Maine Medical Center Lewiston Maine 04240
Mfsmc-Hjwci Baltimore Maryland 21237
Maryland Oncology Hematology, P.A. - Clinton Clinton Maryland 20735
Massachusetts General Hospital Boston Massachusetts 02114
Dana Farber Cancer Institute Boston Massachusetts 02215
MGH Northshore Cancer Center Danvers Massachusetts 01923
Southcoast Centers for Cancer Care Fairhaven Massachusetts 02719
Dana-Farber Cancer Institute - Foxborough Foxborough Massachusetts 02035
Dana Farber Cancer Center Merrimack Valley Methuen Massachusetts 01844
Dana Farber Cancer Institute Milford Massachusetts 01757
Mass General Cancer Center Newton Massachusetts 02462
Dana Farber Cancer Institute South Weymouth Massachusetts 02190
Reliant Medical Group Worcester Massachusetts 01606
St. Vincent Frontier Cancer Center Billings Montana 59102
Dana Farber Cancer Center Londonderry Londonderry New Hampshire 03053
University of New Mexico Comprehensive Cancer Center Albuquerque New Mexico 87106
Lifespan Cancer Institute Providence Rhode Island 02906
Tennessee Oncology-Chattanooga /Sarah Cannon Research Institute/SCRI Chattanooga Tennessee 37404
Sarah Cannon Research Institute/SCRI Nashville Tennessee 37203
Tennessee Oncology-Nashville/Sarah Cannon Research Institute/SCRI Nashville Tennessee 37203
Texas Oncology - Bedford Bedford Texas 76022
Texas Oncology - Denton Denton Texas 76201
Texas Oncology, P.A. El Paso Texas 79902
University of Texas MD Anderson Cancer Center Houston Texas 77030-4009
Texas Oncology - McKinney McKinney Texas 75071
Woodlands Medical Specialists, PA McKinney Texas 75071
Woodlands Medical Specialists, PA Mesquite Texas 75150
Texas Oncology - Plano East Plano Texas 75075-7787
Texas Oncology-Plano West Plano Texas 75093
Mays Cancer Center San Antonio Texas 78229
US Oncology The Woodlands Texas 77380
Texas Oncology - Tyler Cancer Center Tyler Texas 75702
Intermountain Medical Center Murray Utah 84107
Intermountain Healthcare - St. George St. George Utah 84790
The University of Vermont Medical Center Inc. Burlington Vermont 05401
Shenandoah Oncology, P.C. Winchester Virginia 22601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 78 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05169567, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 15, 2026 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05169567 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →